| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.0007 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.54 | 0.002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.14 | 0.002 |